Carzomib Carfilzomib 60mg Injection

  • Product Name : Carzomib Carfilzomib 60mg Injection
  • Category : Injection
  • Manufacturer Name : Hetero Healthcare
  • Trade Name :
  • Available Dosage : 60 mg
  • Packing : Vial
  • Pack Insert/Leaflet :
  • Ingredients : Carfilzomib
  • Formulation : Injection
  • Therapeutic use :
  • Production Capacity : 100000

Description:-

Introduction to Carzomib Injection:


Carzomib 60mg Injection is used in the treatment of multiple myeloma. It works by stopping or slowing down the growth of cancer cells.


Carzomib 60mg Injection is administered as an injection by a qualified medical professional. Your doctor will determine the necessary dose and frequency of administration. This will depend on the condition you are being treated for and may change over time. You should take it exactly as your doctor has advised. Taking it incorrectly or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to.


Uses of Carzomib Injection:

Multiple myeloma


Benefits of Carzomib Injection:


In Multiple myeloma:

If you have multiple myeloma, your body is destroying bone faster than it is being replaced. This makes bones weak, painful, and more likely to break. Carzomib 60mg Injection may be prescribed along with other cancer treatments such as chemotherapy. It is an important part of your treatment and increases the survival rate of people with multiple myeloma. This medicine will kill the cancerous cells and prevent their further growth as well as spread to other parts of the body. Follow your doctors instructions carefully to get the most benefit. Supplements of calcium and Vitamin D3 are also effective and may be prescribed if you do not have high blood calcium levels.


Mechanism of Action of Carzomib Injection:


Carzomib 60mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in the number of proteins in the cancer cells leading to their death.